$CERS
CERUS CORP

2017 Q4 Form 10-K Financial Statement

#000156459018004969 Filed on March 08, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2017 Q3 2017 Q2
Revenue $16.24M $10.80M $9.525M
YoY Change 60.4% 6.11% 2.96%
Cost Of Revenue $9.130M $5.350M $4.360M
YoY Change 62.75% -1.83% -12.38%
Gross Profit $9.490M $5.449M $5.165M
YoY Change 109.96% 15.35% 20.82%
Gross Profit Margin 58.44% 50.47% 54.23%
Selling, General & Admin $12.51M $12.18M $14.09M
YoY Change 0.56% 0.16% 13.57%
% of Gross Profit 131.82% 223.53% 272.8%
Research & Development $7.780M $7.886M $8.890M
YoY Change -11.79% 12.13% 3.89%
% of Gross Profit 81.98% 144.72% 172.12%
Depreciation & Amortization $450.0K $460.0K $430.0K
YoY Change 4.65% 6.98% -10.42%
% of Gross Profit 4.74% 8.44% 8.33%
Operating Expenses $20.34M $20.12M $23.04M
YoY Change -4.51% 4.53% 9.62%
Operating Profit -$10.85M -$12.38M -$16.20M
YoY Change -35.34% -13.16% -3.2%
Interest Expense -$850.0K $1.090M $501.0K
YoY Change 88.89% 86.01% -23.86%
% of Operating Profit
Other Income/Expense, Net $140.0K -$986.0K $2.997M
YoY Change -83.53% 84.99% -775.0%
Pretax Income -$11.56M -$13.37M -$13.21M
YoY Change -21.41% -9.63% -23.14%
Income Tax -$70.00K $50.00K $3.876M
% Of Pretax Income
Net Earnings -$11.49M -$13.42M -$17.08M
YoY Change -14.92% -6.66% -5.96%
Net Earnings / Revenue -70.73% -124.28% -179.35%
Basic Earnings Per Share -$0.10 -$0.12 -$0.16
Diluted Earnings Per Share -$0.10 -$0.12 -$0.16
COMMON SHARES
Basic Shares Outstanding 109.8M 105.0M
Diluted Shares Outstanding 109.8M 105.0M

Balance Sheet

Concept 2017 Q4 2017 Q3 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.70M $59.60M $50.90M
YoY Change -10.31% -26.6% -39.44%
Cash & Equivalents $13.68M $17.24M $20.53M
Short-Term Investments $47.01M $42.60M $30.60M
Other Short-Term Assets $2.330M $4.100M $3.300M
YoY Change 29.16% -43.06% -38.26%
Inventory $14.46M $14.30M $12.20M
Prepaid Expenses $1.221M
Receivables $12.42M $10.50M $7.900M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $89.90M $88.40M $74.30M
YoY Change -4.47% -18.15% -33.79%
LONG-TERM ASSETS
Property, Plant & Equipment $2.119M $2.300M $2.700M
YoY Change -29.01% -28.13% -16.04%
Goodwill $1.316M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.128M $4.400M $4.600M
YoY Change -0.48% 57.14% 100.61%
Total Long-Term Assets $8.346M $8.700M $9.200M
YoY Change -10.94% 7.41% 11.66%
TOTAL ASSETS
Total Short-Term Assets $89.90M $88.40M $74.30M
Total Long-Term Assets $8.346M $8.700M $9.200M
Total Assets $98.24M $97.10M $83.50M
YoY Change -5.06% -16.37% -30.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.97M $12.50M $9.600M
YoY Change 27.8% 81.16% 33.52%
Accrued Expenses $11.71M $10.70M $9.300M
YoY Change 4.4% 4.9% -1.47%
Deferred Revenue $445.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $5.500M
YoY Change -100.0% -9.84%
Total Short-Term Liabilities $23.13M $23.90M $25.30M
YoY Change -13.97% 4.37% -1.56%
LONG-TERM LIABILITIES
Long-Term Debt $29.80M $29.80M $11.90M
YoY Change 140.32% 106.94% -13.14%
Other Long-Term Liabilities $609.0K $6.300M $7.000M
YoY Change -61.7% -1.56% 416.22%
Total Long-Term Liabilities $609.0K $36.10M $18.90M
YoY Change -61.7% 73.56% 1293.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.13M $23.90M $25.30M
Total Long-Term Liabilities $609.0K $36.10M $18.90M
Total Liabilities $59.30M $59.90M $44.20M
YoY Change 29.8% 36.76% -3.51%
SHAREHOLDERS EQUITY
Retained Earnings -$721.3M -$709.8M
YoY Change 9.17%
Common Stock $760.3M $747.0M
YoY Change 5.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $38.94M $37.18M $39.30M
YoY Change
Total Liabilities & Shareholders Equity $98.24M $97.09M $83.50M
YoY Change -5.06% -16.38% -30.71%

Cashflow Statement

Concept 2017 Q4 2017 Q3 2017 Q2
OPERATING ACTIVITIES
Net Income -$11.49M -$13.42M -$17.08M
YoY Change -14.92% -6.66% -5.96%
Depreciation, Depletion And Amortization $450.0K $460.0K $430.0K
YoY Change 4.65% 6.98% -10.42%
Cash From Operating Activities -$10.04M -$12.85M -$13.00M
YoY Change 3.4% -20.92% -10.53%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$160.0K
YoY Change -100.0% -100.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities -$4.610M -$12.34M $11.86M
YoY Change -124.39% -196.71% -298.33%
Cash From Investing Activities -$4.610M -$12.33M $11.68M
YoY Change -124.65% -198.48% -293.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.33M 21.90M 10.65M
YoY Change 3676.67% 146.62% 41.62%
NET CHANGE
Cash From Operating Activities -10.04M -12.85M -13.00M
Cash From Investing Activities -4.610M -12.33M 11.68M
Cash From Financing Activities 11.33M 21.90M 10.65M
Net Change In Cash -3.320M -3.280M 9.330M
YoY Change -135.74% -163.69% -171.44%
FREE CASH FLOW
Cash From Operating Activities -$10.04M -$12.85M -$13.00M
Capital Expenditures $0.00 $0.00 -$160.0K
Free Cash Flow -$10.04M -$12.85M -$12.84M
YoY Change 5.57% -19.74% -11.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2015 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
10759000
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
129597267
CY2017Q2 dei Entity Public Float
EntityPublicFloat
238000000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13683000
CY2017Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
47013000
CY2016Q4 us-gaap Available For Sale Securities Equity Securities Current
AvailableForSaleSecuritiesEquitySecuritiesCurrent
3952000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12415000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6868000
CY2017Q4 us-gaap Inventory Net
InventoryNet
14457000
CY2016Q4 us-gaap Inventory Net
InventoryNet
12531000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1221000
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1274000
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1109000
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1804000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
149000
CY2017Q4 cers Accrual For Manufacturing And Development Payment Liability Noncurrent
AccrualForManufacturingAndDevelopmentPaymentLiabilityNoncurrent
5766000
CY2017 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-12-31
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Trading Symbol
TradingSymbol
CERS
CY2017 dei Entity Registrant Name
EntityRegistrantName
CERUS CORP
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0001020214
CY2017 dei Document Type
DocumentType
10-K
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
445000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26888000
CY2016Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
6934000
CY2017 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
21037000
CY2016 us-gaap Interest Expense
InterestExpense
2445000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-57530000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
71000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-61447000
CY2016 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
16888000
CY2017 us-gaap Operating Expenses
OperatingExpenses
86325000
CY2016 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
31322000
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
45989000
CY2015 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
25643000
CY2016 us-gaap Operating Expenses
OperatingExpenses
80427000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-61075000
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10000
CY2015 us-gaap Operating Expenses
OperatingExpenses
71834000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22560000
CY2016Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
45116000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9355000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7186000
CY2015 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-396000
CY2015 us-gaap Interest Expense
InterestExpense
1705000
CY2016 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
21000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-200000
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7320000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
184000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4148000
CY2017Q4 us-gaap Assets
Assets
98244000
CY2016Q4 us-gaap Assets
Assets
103476000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10974000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8587000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11712000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11218000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
103000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
760225000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-660718000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
89898000
CY2017Q4 us-gaap Goodwill
Goodwill
1316000
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
536000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
247000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4128000
CY2016Q4 cers Accrual For Manufacturing And Development Payment Liability Noncurrent
AccrualForManufacturingAndDevelopmentPaymentLiabilityNoncurrent
4770000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
94105000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2119000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2985000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
38940000
CY2016Q4 us-gaap Goodwill
Goodwill
1316000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
57787000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
738000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
98244000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
103476000
CY2016Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
12441000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
609000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1590000
CY2017Q4 us-gaap Liabilities
Liabilities
59304000
CY2016Q4 us-gaap Liabilities
Liabilities
45689000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
115000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48753000
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
225000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
115555000
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
103475000
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
103475000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6730000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8065000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23131000
CY2017Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
29798000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-97000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
103000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-721303000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3887000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-60585000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
718299000
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96905000
CY2017 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
43568000
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
37183000
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2605000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2511000
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
34223000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
115555000
CY2017 us-gaap Cost Of Goods Sold
CostOfGoodsSold
22531000
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
20295000
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
23464000
CY2017 us-gaap Contracts Revenue
ContractsRevenue
7758000
CY2016 us-gaap Contracts Revenue
ContractsRevenue
2092000
CY2017 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
33710000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
52413000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
202000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
202000
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
202000
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
150000
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3566000
CY2017 us-gaap Interest Expense
InterestExpense
3022000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3864000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1140000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
832000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1284000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1536000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-56698000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62731000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59539000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
175000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3671000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-62906000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-55868000
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-200000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-60785000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-70092000
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
3825000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
41521000
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
75376000
CY2015 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Purchases From Employee Stock Purchase Plans Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndPurchasesFromEmployeeStockPurchasePlansValue
19686000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
94765000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21981000
CY2016 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Purchases From Employee Stock Purchase Plans Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndPurchasesFromEmployeeStockPurchasePlansValue
3068000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
30156000
CY2017 cers Issuance Of Common Stock From Exercise Of Stock Options Or Warrants And Vesting Of Restricted Stock Units And Purchases From Employee Stock Purchase Plans Value
IssuanceOfCommonStockFromExerciseOfStockOptionsOrWarrantsAndVestingOfRestrictedStockUnitsAndPurchasesFromEmployeeStockPurchasePlansValue
2427000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1811000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1817000
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1699000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
9355000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
8065000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
6730000
CY2017 cers Non Cash Interest Expense
NonCashInterestExpense
551000
CY2016 cers Non Cash Interest Expense
NonCashInterestExpense
1017000
CY2015 cers Non Cash Interest Expense
NonCashInterestExpense
508000
CY2015 cers Noncash Deferred Manufacturing And Development Expense
NoncashDeferredManufacturingAndDevelopmentExpense
434000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-119000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
28000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7000
CY2017 cers Non Cash Tax Expense Benefit From Other Unrealized Gain Loss On Available For Sale Securities
NonCashTaxExpenseBenefitFromOtherUnrealizedGainLossOnAvailableForSaleSecurities
3825000
CY2015 cers Non Cash Tax Expense Benefit From Other Unrealized Gain Loss On Available For Sale Securities
NonCashTaxExpenseBenefitFromOtherUnrealizedGainLossOnAvailableForSaleSecurities
-3825000
CY2017 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
3466000
CY2016 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
750000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-48548000
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108221000
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101826000
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96068000
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108221000
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101826000
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7186000
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7320000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5547000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1074000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
301000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2092000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
24567000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
43000000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1781000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3991000
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1107000
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1327000
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1379000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2487000
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3261000
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3866000
CY2017 cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
-507000
CY2016 cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
1330000
CY2015 cers Increase Decrease In Accrued Liabilities And Other Noncurrent Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherNoncurrentLiabilities
1359000
CY2017 cers Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
680000
CY2016 cers Increase Decrease In Manufacturing And Development Payment Liability
IncreaseDecreaseInManufacturingAndDevelopmentPaymentLiability
-3568000
CY2017 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
265000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-445000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
190000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-52235000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-53529000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-51129000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
353000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
563000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
722000
CY2017 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
68792000
CY2016 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
82811000
CY2015 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
90407000
CY2017 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
69566000
CY2016 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
63450000
CY2015 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
92645000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
421000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-19924000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1516000
CY2017 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2428000
CY2016 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3068000
CY2015 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
12767000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30197000
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22121000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
75300000
CY2017 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
30000000
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
10000000
CY2017 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
19625000
CY2016 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
622000
CY2015 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
113000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
97954000
CY2017 cers Cash Cash Equivalents And Restricted Cash Period Increase Decrease
CashCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
-8814000
CY2016 cers Cash Cash Equivalents And Restricted Cash Period Increase Decrease
CashCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
-48886000
CY2015 cers Cash Cash Equivalents And Restricted Cash Period Increase Decrease
CashCashEquivalentsAndRestrictedCashPeriodIncreaseDecrease
48341000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22744000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71630000
CY2014Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23289000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13930000
CY2017 us-gaap Interest Paid
InterestPaid
2034000
CY2016 us-gaap Interest Paid
InterestPaid
1366000
CY2015 us-gaap Interest Paid
InterestPaid
1087000
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
160000
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
157000
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
153000
CY2015 cers Noncash Manufacturing And Development Obligation
NoncashManufacturingAndDevelopmentObligation
7051000
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates its estimates, including those related to the accounts receivable, inventory reserves, fair values of investments, stock-based compensation, intangible assets and goodwill, useful lives of intangible assets and property and equipment, income taxes, and accrued liabilities, among others. The Company bases its estimates on historical experience, future projections, and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions.</p></div>
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, available-for-sale securities and accounts receivable.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the Company&#8217;s investment policy, substantially all of the Company&#8217;s cash, cash equivalents and available-for-sale securities are maintained at major financial institutions of high credit standing. The Company monitors the financial credit worthiness of the issuers of its investments and limits the concentration in individual securities and types of investments that exist within its investment portfolio. Generally, all of the Company&#8217;s investments carry high credit quality ratings, which is in accordance with its investment policy.&#160;At December&#160;31, 2017, the Company does not believe there is significant financial risk from non-performance by the issuers of the Company&#8217;s cash equivalents and short-term investments.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of credit risk with respect to trade receivables exist. On a regular basis, including at the time of sale, the Company performs credit evaluations of its significant customers that it expects to sell to on credit terms. Generally, the Company does not require collateral from its customers to secure accounts receivable. To the extent that the Company determines specific invoices or customer accounts may be uncollectible, the Company establishes an allowance for doubtful accounts against the accounts receivable on its consolidated balance sheets and records a charge on its consolidated statements of operations as a component of selling, general and administrative expenses.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had three customers that accounted for more than 10% of the Company&#8217;s outstanding trade receivables at both December&#160;31, 2017 and 2016. These customers cumulatively represented approximately 53% and 46% of the Company&#8217;s outstanding trade receivables at December&#160;31, 2017 and 2016, respectively. To date, the Company has not experienced collection difficulties from these customers.</p></div>
CY2017 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2017 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div> <p style="text-align:justify;margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Guarantee and Indemnification Arrangements</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes the fair value for guarantee and indemnification arrangements issued or modified by the Company. In addition, the Company monitors the conditions that are subject to the guarantees and indemnifications in order to identify if a loss has occurred. If the Company determines it is probable that a loss has occurred, then any such estimable loss would be recognized under those guarantees and indemnifications. Some of the agreements that the Company is a party to contain provisions that indemnify the counter party from damages and costs resulting from claims that the Company&#8217;s technology infringes the intellectual property rights of a third party or claims that the sale or use of the Company&#8217;s products have caused personal injury or other damage or loss. The Company has not received any such requests for indemnification under these provisions and has not been required to make material payments pursuant to these provisions.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company generally provides for a one-year warranty on certain of its INTERCEPT blood-safety products covering defects in materials and workmanship. The Company accrues costs associated with warranty obligations when claims become known and are estimable. The Company has not experienced significant or systemic warranty claims nor is it aware of any existing current warranty claims. Accordingly, the Company had not accrued for any future warranty costs for its products at December&#160;31, 2017 and 2016.</p></div>
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13686000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
97000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
44514000
CY2017Q4 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
0
CY2016Q4 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
0
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
12032000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
38781000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
54107000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
11990000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
44514000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
97000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
40121000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
24000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
40121000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
24000
CY2017 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2016 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2017Q4 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
3
CY2016Q4 cers Cumulative Outstanding Trade Receivables Number Of Major Customers
CumulativeOutstandingTradeReceivablesNumberOfMajorCustomers
3
CY2017 cers Work In Process Inventory Life Period
WorkInProcessInventoryLifePeriod
P1Y
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2016Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
100000
CY2017 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P10Y
CY2017 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2015 us-gaap Dilutive Securities
DilutiveSecurities
-3566000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-60585000
CY2016 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-62906000
CY2015 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-59434000
CY2015 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
837000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
18619000
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16211000
CY2017 cers Product Warranty Term
ProductWarrantyTerm
P1Y
CY2017Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2016Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
0
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
50868000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
97000
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
50771000
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
54131000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3952000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
24000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
58059000
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
38836000
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
54131000
CY2015 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2017 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
3500000
CY2016 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
800000
CY2015 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
800000
CY2016 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2015 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4299000
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5044000
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
10158000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7487000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13513000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13272000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11394000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10287000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1200000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1100000
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1100000
CY2017 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2015 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2017000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1481000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2017000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1279000
CY2017 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2016 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2015 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
200000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
200000
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
100000
CY2017 cers Eligible To Receive Royalty Fee
EligibleToReceiveRoyaltyFee
0.01
CY2017 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
0
CY2016 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
0
CY2015 us-gaap Royalty Income Nonoperating
RoyaltyIncomeNonoperating
0
CY2017Q4 us-gaap Cost Method Investments
CostMethodInvestments
0
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7372000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7098000
CY2017Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
507000
CY2016Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
476000
CY2017Q4 cers Accrued Customer Costs Current
AccruedCustomerCostsCurrent
481000
CY2016Q4 cers Accrued Customer Costs Current
AccruedCustomerCostsCurrent
534000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
747000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
599000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
7857000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
8571000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8572000
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
5000000
CY2017Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2017Q4 cers Longterm Debt Maturities Repayments Of Interest In Next Twelve Months
LongtermDebtMaturitiesRepaymentsOfInterestInNextTwelveMonths
2554000
CY2017Q4 cers Long Term Debt Maturities Repayments Of Interest In Year Two
LongTermDebtMaturitiesRepaymentsOfInterestInYearTwo
2280000
CY2017Q4 cers Long Term Debt Maturities Repayments Of Interest In Year Three
LongTermDebtMaturitiesRepaymentsOfInterestInYearThree
1558000
CY2017Q4 cers Long Term Debt Maturities Repayments Of Interest In Year Four
LongTermDebtMaturitiesRepaymentsOfInterestInYearFour
822000
CY2017Q4 cers Long Term Debt Maturities Repayments Of Interest In Year Five
LongTermDebtMaturitiesRepaymentsOfInterestInYearFive
2542000
CY2017Q4 cers Long Term Debt Maturities Repayments Of Interest
LongTermDebtMaturitiesRepaymentsOfInterest
9756000
CY2017Q4 cers Long Term Debt Maturities Repayments Of Principal And Interest In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInNextTwelveMonths
2554000
CY2017Q4 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearTwo
10137000
CY2017Q4 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearThree
10129000
CY2017Q4 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFour
9394000
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017Q4 cers Long Term Debt Maturities Repayments Of Principal And Interest In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearFive
7542000
CY2017Q4 cers Long Term Debt Maturities Repayments Of Principal And Interest
LongTermDebtMaturitiesRepaymentsOfPrincipalAndInterest
39756000
CY2017 cers Minimum Term Of Non Cancelable Operating Leases
MinimumTermOfNonCancelableOperatingLeases
P1Y
CY2017 cers Expiration Of Non Cancelable Operating Leases Maximum Year
ExpirationOfNonCancelableOperatingLeasesMaximumYear
2023
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1387000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1169000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
239000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
200000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
177000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
17000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
3189000
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1000000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
800000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
800000
CY2010 cers Proceeds From Landlord Financing Leasehold Improvement
ProceedsFromLandlordFinancingLeaseholdImprovement
1100000
CY2017Q4 cers Accrued Leasehold Improvements Current And Accrued Leasehold Improvements Noncurrent
AccruedLeaseholdImprovementsCurrentAndAccruedLeaseholdImprovementsNoncurrent
300000
CY2017 cers Purchase Commitment Payments
PurchaseCommitmentPayments
6700000
CY2016 cers Purchase Commitment Payments
PurchaseCommitmentPayments
6900000
CY2015 cers Purchase Commitment Payments
PurchaseCommitmentPayments
7700000
CY2017Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
9600000
CY2017Q4 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
2400000
CY2017Q4 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
2600000
CY2017Q4 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
4900000
CY2017 cers Agreement Expiration Date
AgreementExpirationDate
2014-09-30
CY2017 cers Maximum Termination Penalty
MaximumTerminationPenalty
3000000
CY2017 cers Stockholders Rights Plan Expiration Date
StockholdersRightsPlanExpirationDate
2019-10-27
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1900000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1200000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8065000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6730000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.55
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.35
CY2017 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.60
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2015 cers Payment For Manufacturing Of Entity Products
PaymentForManufacturingOfEntityProducts
14900000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-57925000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-63246000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-59897000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1227000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
515000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
358000
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
181000
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
147000
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
147000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
169411000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-16863000
CY2016Q4 cers Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
22575000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
7011000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
8242000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3116000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3184000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
181000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
147000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
147000
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3659000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
28000
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3750000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
47000
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-68000
CY2017 cers Deferred Income Tax Expense Benefit And Tax Benefit From Unrealized Gain On Available For Sale Securities Operating Activities
DeferredIncomeTaxExpenseBenefitAndTaxBenefitFromUnrealizedGainOnAvailableForSaleSecuritiesOperatingActivities
3706000
CY2016 cers Deferred Income Tax Expense Benefit And Tax Benefit From Unrealized Gain On Available For Sale Securities Operating Activities
DeferredIncomeTaxExpenseBenefitAndTaxBenefitFromUnrealizedGainOnAvailableForSaleSecuritiesOperatingActivities
28000
CY2015 cers Deferred Income Tax Expense Benefit And Tax Benefit From Unrealized Gain On Available For Sale Securities Operating Activities
DeferredIncomeTaxExpenseBenefitAndTaxBenefitFromUnrealizedGainOnAvailableForSaleSecuritiesOperatingActivities
-3818000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-19277000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-21329000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-20243000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
81923000
CY2017 cers Income Tax Reconciliation Change In Enacted Tax Rate Deemed Income Inclusion
IncomeTaxReconciliationChangeInEnactedTaxRateDeemedIncomeInclusion
1083000
CY2017 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1000000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
809000
CY2015 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
838000
CY2015 cers Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
-3565000
CY2015 cers Income Tax Reconciliation Expiration Of Federal Net Operating Losses
IncomeTaxReconciliationExpirationOfFederalNetOperatingLosses
3337000
CY2017 cers Income Tax Reconciliation Expiration Of State And Local Net Operating Losses
IncomeTaxReconciliationExpirationOfStateAndLocalNetOperatingLosses
-1475000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-59462000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
3940000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
11754000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
1382000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
484000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
449000
CY2015 cers Effective Income Tax Rate Reconciliation Change In State Apportionment
EffectiveIncomeTaxRateReconciliationChangeInStateApportionment
4085000
CY2016 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
17200000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-2237000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
689000
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1350000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
117028000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
176490000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
25061000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
22128000
CY2017Q4 cers Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
17195000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
232619000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
169332000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
228794000
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
79000
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3825000
CY2016Q4 cers Deferred Tax Liabilities Unrealized Gains On Investments
DeferredTaxLiabilitiesUnrealizedGainsOnInvestments
3825000
CY2017Q4 cers Deferred Tax Liabilities Amortization Of Intangible Assets
DeferredTaxLiabilitiesAmortizationOfIntangibleAssets
111000
CY2016Q4 cers Deferred Tax Liabilities Amortization Of Intangible Assets
DeferredTaxLiabilitiesAmortizationOfIntangibleAssets
150000
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
111000
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7632000
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3975000
CY2017 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
-59500000
CY2016 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
3900000
CY2015 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
11800000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
531303000
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
73860000
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
610000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10836000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
19000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
10691000
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
207000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
145000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11062000
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2017 us-gaap Revenues
Revenues
51326000
CY2016 us-gaap Revenues
Revenues
39275000
CY2015 us-gaap Revenues
Revenues
34223000
CY2017Q4 us-gaap Noncurrent Assets
NoncurrentAssets
2655000
CY2016Q4 us-gaap Noncurrent Assets
NoncurrentAssets
3723000
CY2017Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7006000
CY2017Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9525000
CY2017Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10797000
CY2017Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
16240000
CY2017Q1 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
3312000
CY2017Q2 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
5165000
CY2017Q3 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
5449000
CY2017Q4 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
7111000
CY2017Q1 us-gaap Contracts Revenue
ContractsRevenue
1428000
CY2017Q2 us-gaap Contracts Revenue
ContractsRevenue
1667000
CY2017Q3 us-gaap Contracts Revenue
ContractsRevenue
2285000
CY2017Q4 us-gaap Contracts Revenue
ContractsRevenue
2378000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-18598000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-17083000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-13418000
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-11486000
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9251000
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10175000
CY2016Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10125000
CY2016Q1 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
3369000
CY2016Q2 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
4275000
CY2016Q3 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
4724000
CY2016Q4 cers Gross Profit On Product Revenue
GrossProfitOnProductRevenue
4520000
CY2016Q3 us-gaap Contracts Revenue
ContractsRevenue
261000
CY2016Q4 us-gaap Contracts Revenue
ContractsRevenue
1831000
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-18166000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-14376000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-13501000
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13

Files In Submission

Name View Source Status
0001564590-18-004969-index-headers.html Edgar Link pending
0001564590-18-004969-index.html Edgar Link pending
0001564590-18-004969.txt Edgar Link pending
0001564590-18-004969-xbrl.zip Edgar Link pending
cers-10k_20171231.htm Edgar Link pending
cers-20171231.xml Edgar Link completed
cers-20171231.xsd Edgar Link pending
cers-20171231_cal.xml Edgar Link unprocessable
cers-20171231_def.xml Edgar Link unprocessable
cers-20171231_lab.xml Edgar Link unprocessable
cers-20171231_pre.xml Edgar Link unprocessable
cers-ex121_8.htm Edgar Link pending
cers-ex211_10.htm Edgar Link pending
cers-ex231_6.htm Edgar Link pending
cers-ex311_7.htm Edgar Link pending
cers-ex312_11.htm Edgar Link pending
cers-ex321_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2018030820230854148078.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending